Search results
Mustang Bio stock tumbles 27% amid news of mass layoffs (NASDAQ:MBIO)
Seeking Alpha· 16 hours agoMustang Bio (MBIO) stock tumbled 27% Monday in the wake of news that the company plans to cut around...
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The...
WSYR 9 Syracuse· 2 hours agoThe Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. (NASDAQ: BLUE). Shareholders who purchased shares of BLUE during the class period listed ...
Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares
GuruFocus.com via Yahoo Finance· 13 hours agoNatalie Holles, CEO of Third Harmonic Bio Inc (NASDAQ:THRD), has sold 13,558 shares of the company...
Imugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 million
Proactive Investors· 11 hours ago:IMU, OTC:IUGNF) managing director and CEO Leslie Chong sits down with Proactive’s Jonathan Jackson...
Earnings call: OncoCyte outlines growth strategy and partnership with Bio-Rad By Investing.com
Investing.com· 21 hours agoDuring the earnings call, CEO Josh Riggs provided insights into the company's strategic...
Is Bluebird Bio Stock a Buy?
Motley Fool via Yahoo Finance· 24 hours agoIf a little bird told you to think about buying Bluebird Bio (NASDAQ: BLUE) stock recently, there's a lot of information you'll need to evaluate. Between...
BLUEBIRD BIO, INC. (NASDAQ: BLUE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the...
Morningstar· 21 hours agoDo you, or did you, own shares of bluebird bio, Inc. (NASDAQ: BLUE)? Did you purchase your shares between April 24, 2023 and December 8, 2023, inclusive? Did you lose money ...
Next Bio Invests in Hiperbaric High-Pressure Processing Technology to Ramp Up Cold Brew Coffee...
FOX 8 Cleveland· 19 hours agoMIAMI, April 15, 2024 /PRNewswire/ -- Next Bio, South Korea's top producer of cold brew coffee, has made a major investment in Hiperbaric's High Pressure Processing (HPP) ...
Recent Insider Activity Could Benefit 2seventy bio Inc
Knox Daily· 12 hours ago2seventy bio Inc’s filing revealed that its Director Casdin Capital, LLC acquired Company’s shares for reported $0.2 million on Mar 26 ’24. In the deal valued at $5.10 per ...
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay By Investing.com
Investing.com· 5 days agoOncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced a partnership...
